Sequence Analysis & Mutation Detection Solutions

Infectious Disease Reporting & Mutation Detection


Analysis Solutions

From its origins in HIV drug-resistance testing, Hyrax has extended the Exatype genotyping platform to accommodate any disease or test. Our pipeline is currently being used to report drug resistance in HIV, as well as consensus sequences, mutations, and lineage and clade typing in SARS-CoV-2 (COVID-19).

/images/helix.png HIV SANGER

Consolidated HIV Genotyping solution for sequencing done by capillary electrophoresis (CE), e.g. the Applied Biosystems 3730 and 3500 Series Genetic Analyzers.

A circled information sign

Download PDF

/images/solutions/hiv_proviral.png HIV NGS PROVIRAL

Our proviral solution assists in the selection of drug regimens that are better-tolerated in treatment-experienced people.

A circled information sign

Download PDF

Get Started with a Free Trial View Pricing


The Exatype Platform: An end-to-end Bioinformatics Software Platform

Our modular platform can analyse and interpret sequence data from an ever-expanding range of applications, including:


Genotyping and drug-resistance testing in infectious diseases e.g. HIV, TB, SARS-CoV-2.


Multi-target diagnostics, e.g. infectious disease panels.


Tumour profiling and drug-susceptibility testing in cancer.


Low abundance variant detection e.g. detecting mixed infections or the detection of biomarkers in liquid biopsies.

View our Platform Solutions

A look inside our Exatype NGS analysis software

Your Sequence data.

One Solution.

Discover our sequence-analysis solutions Email sending